Dwyer, J. H., Schmahl, C., Makinodan, M., Fineberg, S. K., Sommer, S., Wruck, J., . . . Goodman, M. (2025). Efficacy and safety of BI 1358894 in patients with borderline personality disorder: Results of a phase 2 randomized, placebo-controlled, parallel group dose-ranging trial. The journal of clinical psychiatry, 86(1), . https://doi.org/10.4088/jcp.24m15523
Chicago-Zitierstil (17. Ausg.)Dwyer, Jennifer Holt, Christian Schmahl, Manabu Makinodan, Sarah K. Fineberg, Stephanie Sommer, Jan Wruck, Ante Jelaska, Abidemi Adeniji, und Marianne Goodman. "Efficacy and Safety of BI 1358894 in Patients with Borderline Personality Disorder: Results of a Phase 2 Randomized, Placebo-controlled, Parallel Group Dose-ranging Trial." The Journal of Clinical Psychiatry 86, no. 1 (2025). https://doi.org/10.4088/jcp.24m15523.
MLA-Zitierstil (9. Ausg.)Dwyer, Jennifer Holt, et al. "Efficacy and Safety of BI 1358894 in Patients with Borderline Personality Disorder: Results of a Phase 2 Randomized, Placebo-controlled, Parallel Group Dose-ranging Trial." The Journal of Clinical Psychiatry, vol. 86, no. 1, 2025, https://doi.org/10.4088/jcp.24m15523.